« Back to Record
Citation APA

De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-007279


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/366859

De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-007279